drug repositioning

Biotech

Mayo Clinic helps tech-enabled R&D shop nference to $60M B round

Nference thinks its platform can help identify new targets and drug combinations by corralling existing data.
Nick Paul Taylor Jan 8, 2020 8:11am

Healx raises $56M to launch 40 rare disease R&D programs

Oct 16, 2019 3:00am

Healx reels in $10M in series A funding for work on rare diseases

Jul 27, 2018 11:17am

BTI files for $69M IPO to run trials in Alzheimer's and cancer

Feb 13, 2018 8:39am

Roivant bags AstraZeneca drug in latest bid

Oct 20, 2017 8:53am

Mayo Clinic startup raises series A round for AI-driven R&D

Jul 14, 2017 6:04am